Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$301.4 - $428.42 $31.1 Million - $44.2 Million
-103,197 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$379.46 - $424.54 $4.7 Million - $5.26 Million
-12,381 Reduced 10.71%
103,197 $43.1 Million
Q4 2021

Feb 14, 2022

SELL
$373.53 - $434.12 $61.7 Million - $71.7 Million
-165,120 Reduced 58.82%
115,578 $48.4 Million
Q3 2021

Nov 12, 2021

SELL
$396.76 - $455.92 $17.7 Million - $20.4 Million
-44,687 Reduced 13.73%
280,698 $116 Million
Q2 2021

Aug 12, 2021

SELL
$372.36 - $412.07 $5.51 Million - $6.09 Million
-14,786 Reduced 4.35%
325,385 $129 Million
Q1 2021

May 13, 2021

BUY
$357.26 - $392.57 $1.25 Million - $1.37 Million
3,497 Added 1.04%
340,171 $131 Million
Q4 2020

Feb 12, 2021

BUY
$319.05 - $363.32 $4.09 Million - $4.66 Million
12,818 Added 3.96%
336,674 $122 Million
Q3 2020

Nov 13, 2020

BUY
$280.08 - $347.78 $21.7 Million - $26.9 Million
77,425 Added 31.42%
323,856 $109 Million
Q2 2020

Aug 14, 2020

BUY
$270.93 - $320.3 $9.81 Million - $11.6 Million
36,197 Added 17.22%
246,431 $69.9 Million
Q1 2020

May 12, 2020

BUY
$243.44 - $359.98 $1.99 Million - $2.94 Million
8,178 Added 4.05%
210,234 $58 Million
Q4 2019

Feb 12, 2020

BUY
$281.18 - $322.05 $4.45 Million - $5.1 Million
15,829 Added 8.5%
202,056 $64.9 Million
Q3 2019

Nov 14, 2019

BUY
$294.25 - $341.49 $23.3 Million - $27 Million
79,206 Added 74.01%
186,227 $55.3 Million
Q2 2019

Aug 13, 2019

BUY
$279.29 - $336.89 $185,169 - $223,358
663 Added 0.62%
107,021 $36.1 Million
Q1 2019

May 14, 2019

BUY
$246.18 - $297.25 $1.05 Million - $1.26 Million
4,246 Added 4.16%
106,358 $31.5 Million
Q4 2018

Feb 12, 2019

BUY
$232.7 - $281.66 $23.8 Million - $28.8 Million
102,112 New
102,112 $26 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Atlanta Capital Management CO L L C Portfolio

Follow Atlanta Capital Management CO L L C and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlanta Capital Management CO L L C, based on Form 13F filings with the SEC.

News

Stay updated on Atlanta Capital Management CO L L C with notifications on news.